Markets & Investing
Why Do We Need a Women In Psychedelics Network?: Mindshifting Moments #11
Najla Guthrie, the Founder of the Women in Psychedelics Network joins host Margaret Williamson in this important conversation about equity, equality, and…
Najla Guthrie, the Founder of the Women in Psychedelics Network joins host Margaret Williamson in this important conversation about equity, equality, and empowerment.
As the psychedelics industry continues to grow, it’s important that we identify opportunities for everyone. During this conversation, the pair emphasizes the importance of women in the board room and how that crucial sentiment holds true across all characteristics, attributes, and groups of people.
How Can We Lift Women Up?
The psychedelics industry, or any nascent industry for that matter, has a real opportunity to completely change how we look at power, control, and equity. With new technologies, the right policies, and true empowerment, this industry is well-positioned to influence others about “how it could be.”
To accomplish this, though, it requires the right intentions. Organizations must establish guard rails, encourage open-mindedness, celebrate a wide breadth of opinions and beliefs, and execute.
At Psychedelic Invest, we’re excited to embrace positive change and will continue to lift up every woman that deserves more and better opportunities.
Transcription
The transcription will be available after the event.
-
Psilocybin1 week ago
Are Shrooms Legal in Oregon: Full Guide
-
Psychedelics1 week ago
Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Law & Regulation1 week ago
Clearmind signs agreement with Hebrew University for psychedelic compound rights
-
Psilocybin1 week ago
California advances bill for psychedelics centers
-
Psychedelics1 week ago
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
-
Psychedelics1 week ago
Psychedelics Can Offer More Than Therapy On Its Own
-
Psychedelics1 week ago
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product
-
Psilocybin3 days ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush